View Article

Abstract

In the present study we concluded that, the formulation and assessment of sustained release tablets utilizing natural polymers are the main topics of the review. Long-term medication release is the goal of sustained release (SR) dose forms, which increase patient compliance and therapeutic efficacy. The benefits and drawbacks of sustained release tablets are covered in the study along with preparation techniques and the many natural polymers that are utilized in these formulations. Natural polymers that have been shown to improve drug release characteristics include chitosan, starch, cellulose, xanthan gum, guar gum, and gum karaya. Evaluation tests for sustained release tablets are also covered in the study, including testing for in-vitro dissolution, thickness, diameter, weight fluctuation, hardness, friability, and content homogeneity. According to the results, prolonged release tablets specially those made of natural polymers offer a number of advantages over traditional dose forms with regard to patient adherence and regulated drug administration.

Keywords

Sustained Release Pellets, Oral Antidiabetic, Natural Polymer

Introduction

The therapeutic efficacy of medications is greatly increased by sustained drug delivery systems.  In sustained release drug delivery systems, drug release-retarding polymers are the main players, and numerous natural, semi-synthetic, and synthetic polymeric materials have been studied for this purpose.  In addition, a number of polymers are frequently used in the development of innovative drug delivery systems, such as those that direct drug administration to a particular area of the gastrointestinal tract or that release the drug in reaction to external stimuli.  The two primary components of any pharmaceutical formulation are the active ingredient and excipients.  Excipients aid in the production of dosage forms and enhance their physicochemical characteristics. Research on the application of natural polymers and their semi-synthetic derivatives in medication delivery is still ongoing.  The most effective polymers in matrix systems are those that delay drug release.  Various polymers have been studied as drug retarding agents, each presenting a different approach to the matrix system.  Matrix systems are often divided into three primary categories based on the characteristics of the retarding polymer: plastic, hydrophilic, and hydrophobic.  The best polymers for delaying drug release are hydrophilic ones, and their application in sustained drug administration is gaining traction (9).  Numerous natural polymers have been studied for their potential as sustained release agents. Creating oral sustained release metformin hydrochloride pellets using natural polymers as a rate-controlling component was the main goal of this project.  The current study investigated the possibility of using natural polymers as an excipient source.  The goal is to create a naturally occurring polymer from Blepharis repens that can be used as a retardant and release rate modifier.  The natural polymer's separation, characterization, and application as a natural retardant are covered in this paper.

MATERIAL AND METHOD

The Blepharis repens plant was collected from the Buldhana region during the winter season. The sample was used for evaluation studies, and the natural polymer's physical state, appearance, color, odor, taste, flow properties, angle of repose, bulk density, tapped density, cars index, Hausner's Ratio, solubility, pH, and viscosity were all examined. Additionally, the natural polymer's extractive value was examined.

Formulation of pellets by using natural polymer & API:

A limited quantity of capsules are filled manually.  Granules with 500 mg of metformin hydrochloride as the active ingredient were precisely weighed and then put into capsules using a spatula.

Evaluation of Metformin Hydrochloride capsule

Weight variation:

The average weight was calculated after a random selection of capsules was made.  After that, each capsule was weighed separately, and the weights of each were compared to the average.

Disintegration test: Place one capsule in each tube, then hang the device in a beaker filled with 60 milliliters of water at 370 degrees Celsius.  The disc may be added if hard capsules float on the water's surface.  After 30 minutes of operation, take the assembly out of the liquid and note any residue that is still visible on the device's screen.

Drug content

Each formulation's capsules were taken, and the pellets were extracted.  After transferring the amount of pellets equal to 10 mg of the drug into a 100 ml volumetric flask and dissolving it with distilled water in a sonicator for 10 to 15 minutes, the mixture was filtered, the appropriate dilutions were made, and the absorbance was measured at 234 nm using a UV spectrophotometer.

In-Vitro dissolution release:

Dissolution test apparatus -1; USP-32; 0.1N HCl as the dissolution media; 900 ml; 37 + 0.5 0C as the temperature; and 50 rpm as the speed.

Procedure:

The dissolving vessel was filled with the capsule.  Five milliliters of the sample were taken out at intervals of two, four, six, eight, ten, and twelve hours.  After every sampling, 5 ml of the dissolving medium is replaced, bringing the total volume of the dissolution fluid to 900 ml.  Six capsules were used in the release studies, and the mean values were displayed against time.  Using a twin beam UV and visible spectrophotometer, each sample was examined at 234 nm in comparison to a reagent blank.  A standard calibration curve was used to determine the medication concentration.

RESULT AND DISCUSSION

Physicochemical characterization of Blepharis repens polymer:

Table No: 1. physicochemical characterization of Blepharis repens polymer:

Sr. No

Properties

Blepharis repens polymer

1

Physical state & Appearance

Fine Powder

2

Odor

No

3

Taste

No

4

Color

yellowish or brown

5

Swelling Index

4

6

Particle Size Distribution

105-400μm

7

Flow Properties

_

 

I. Bulk density

0.41

 

II. Tapped density

0.789

 

III. Hausner’s Ratio

1.241

 

IV. Carr’s compressibility Index

20.124

 

V. Angle of Repose

30.50

8

Solubility

water

9

PH

4.21

10

Viscosity

251.4Cp (at 100 rpm)

11

Ash Content

_

 

I. Total Ash

0.510

 

II. Acid Insoluble Ash

0.153

 

III. Water Soluble Ash

0.04

12

Loss on Drying

1.461%

Phytochemical test

Using the appropriate reagents, phytochemical tests for alkaloids, glycosides, tannins, saponins, and flavonoids were conducted.   The initial test for alkaloids was conducted using Dragendoff's, Mayer's, Wager's, and Hager's reagents, which show that the BR polymer is devoid of alkaloids. To identify glycosides Tests for foaming were conducted.  The presence of glycosides is indicated by the persistent froth that was seen.  To identify tannins. When ferric chloride was used, no deep blue-black color was seen, indicating that tannins were not present.  Saponins are tested using photochemistry.  A foaming test was conducted.  The presence of saponins is indicated by the persistent froth that was seen.  To find flavonoids a lead acetate test was conducted.  Add a tiny amount of lead acetate to the BR solution.  The presence of flavonoids was indicated by the yellow-colored ppt that was seen.

UV- Analysis:

Plotting the absorbance of the standard solution against its concentration at λmax 225 nm yielded the standard calibration curve for the BR polymer.  The linear curve in the BR polymer standard solution had a correlation value of 0.981.  At a chosen λmax, their equation of line was y=0.002x+0.002. Plotting the absorbance of the standard solution against its concentration at λmax 225 nm yielded the standard calibration curve for paliperidone.  With a correlation coefficient of 0.98, the BR polymer's standard solution displayed a linear curve.  At a certain λmax, their equation of line was y=0.098x-0.000.

Micrometrics properties of pellets

The bulkiness of a formulation is measured by its bulk density and tab density.  Due to the spherical shape of the pellets, the results show no discernible difference between the two densities.  Excellent flow properties were obtained when the angle of repose was between 15 and 24 degrees.  The Carr's Index, or compressibility index, ranges from 3 to 13.

Testing the friability of pellets

The formulation of the pellets was determined to be friable between 0% and 0.5%.  All batches were determined to pass the friability test, with a maximum allowable level of 0.6%

In- vitro Dissolution Study

The sustained release capsule of metformin hydrochloride was the subject of 14-hour in vitro drug release research.  The sustained release behavior of each batch was examined in accordance with the experimental design specifications.  Because of the varying content of the capsule, the percent release was found to be significantly varied, ranging from 52.14 percent to 91.34%.

Table No: 2. Optimized composition of Metformin Hydrochloride Capsule with Blepharis repens polymer

Batch

Drug (%)

SCMC (%)

BR (%)

Starch (%)

Magnesium Stearate (%)

IPA:

Water (mL)

Propylene glycol

(%)

Batch no.11

47.1

13.1

18.3

2.6

3.9

8.0

5.98

Table No: 3. Pre-compression parameter of factorial design formulations

Batches

Angle

Repose

Bulk

Density

Tapped

density

Carr’s

Index (%)

Hausner’s

ratio

Batch No.11

19 ± 0.7

0.5360 ± 0.7

0.6245 ± 0.2

6.00±0.1

1.220 ± 0.8

Table No: 4. Post compression parameters of Metformin Hydrochloride Capsule

Batches

Weight loss (%)

(Percent friability) %

% Drug release

% Drug content

Batch no.11

0.3

0.4

72.63

90.82

Table No: 5. Post compression parameters of Metformin Hydrochloride Capsule

Batch no.11

Time (hrs.)

Optimized batch

0

0± 0.0

2

7.32

4

17.53

6

27.30

8

41.25

10

56.12

12

71.26

SUMMARY AND CONCLUSION

Acetone was used as a precipitating solvent to separate the polymer from the macerate in a lab-scale procedure for extracting Blepharis repens powder using hot maceration.  The matrix sustained release pill of metformin hydrochloride was developed using the polymer that was isolated from the powdered Blepharis repens as a release retardant.  Additionally, the composition of Metformin Hydrochloride tablets included additional natural polymers.  The release retardant potential of the polymer derived from Blepharis repens powder was compared to that of other polymers.  According to the current study, a polymer derived from the powdered Blepharis repens was found to have the ability to delay the release of metformin hydrochloride.

REFERENCES

  1. Rishi Kumar, Rishabha Malviya, Promod Kumar Sharma. Pharmaceutical applications and patents in natural polymer used drug delivery system. Advances in Biological Research, 2015; 9(1): 24-32.
  2. Murugesh Shivashankar, MandalBadal Kumar. A review on interpenetrating polymer network. International Journal of Pharmacy and Pharmaceutical Sciences, 2012; 4(5): 1.
  3. Kulkarni Vishakha S, Butte Kishor D and Rathod Sudha S, Natural Polymers – A Comprehensive Review, International Journal of Research in Pharmaceutical and Biomedical Sciences,2012;3(4):1597-1613.
  4. Radha Rani Earle, Lakshmi Usha Ayalasomayajula, G. Loknadh, K.Sai Ram Konda Reddy, L. Ratnakanth, A Review on Natural Polymers Used in Pharmaceutical Dosage     Forms,        International Journal of Science and Research Methodology,2016;3(3):77-88.
  5. Vinod KR, Santos V, Sandhya S. Emerging trends in pharmaceutical polymers. Scholars research library 2010; 2 (1): 172-180.
  6. Bhaskar B, Namdeo S, Sunil D, Birudev K. Natural polymers in drug delivery development. Research Journal of Pharmaceutical Dosage Forms and Technology 2014; 6 (1): 54-57.
  7. Sawan K Rathod, Vinod M Thakare and Hemant s Kanhere, Pharmacognostic and Phytochemical evaluation of Blepharis repens, Journal of Pharmacognocy and Phytochemistry;2020;9(2): 805-809.
  8. Tiwari P et al. Phytochemical screening and extraction: A Review International Pharmaceutical Science. 2011; 1:98-106.
  9. Ghebre-SellassieI, Knoch A. Pelletization Techniques. In: SwarbrickJ, Editor. Encyclopedia of Pharmaceutical Technology, 3rd Edition: Informa Healthcare; 2000. P. 2651-63.
  10. Hirjau M, Nicoara AC, Hirjau V, LupuleasaD.Pelletization techniques used in pharmaceutical fields. PracticaFarmaceutic? 2011; 4 (3-4): 206- 11.
  11. Rahman MA, Ahuja A, BabootaS.Bhavna, Bali V, Saigal N, Ali J. Recent Advances in Pelletization Technique for Oral Drug Delivery: A Review. Current Drug Delivery 2009; 6:122-129. http://dx.doi.org/ 10.2174/156720109787048339 PMid:19418964.
  12. Shettigar R, Damle AV. Controlled release pellets of nitrofurantoin; Ind. J. Pharm. Sci.1996; 5: 179-85.
  13. Helen L, Yliruusi J, Muttonen E. Process Variables of the Radial Screen Extruder, II, Size and Size Distribution of Pellets. Pharm. Tech. Int. 1993, 1, 44–53.
  14. Shah RD, Kabadi M, Pope DG, AugsburgerLL.Physicomechanical characterization of the extrusion-spheronization process. Pharm Res1995; 12: 496– 507.http://dx.doi.org/10.1023/A:1016237509740 PMid:7596983.
  15. Catherine Berthomieu Rainer Hienerwade, Fourier transform infrared (FTIR) spectroscopy, Photosynth Res (2009) 101:157–170.
  16. Madiraju AK, Erion DM, Rahimi Y, et al. Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase. Nature. 2014; 510:542– 546. doi: 10.1038/nature13270.
  17. Griffin SJ, Leaver JK, Irving GJ (2017) Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with type 2 diabetes. Diabetologia DOI:10.1007/s00125-017-4337-9
  18. Cameron AR, Morrison VL, Levin D, et al. Anti-inflammatory effects of metformin irrespective of diabetes status. Circ Res. 2016; 119:652–665. doi: 10.1161/CIRCRESAHA.116.308445.
  19. Bannister CA, Holden SE, Jenkins-Jones S, et al. Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls. Diabetes Obes Metab. 2014; 16:1165–1173. doi: 10.1111/dom.12354.
  20. Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus: present and future perspectives. Nature reviews endocrinology. Available at: www.nature.com/uidfinder (Accessed 22nd December 2011)
  21. Genetic basis of type 1 and type2 diabetes, obesity, and their complications. Advances and emerging opportunities in diabetes research: a Strategic Planning report of the DMICC. www2.niddk.nih.gov/NR (Accessed 22nd December 2011).
  22. Department of Health and Human Services. Centres for Disease Control and Prevention, 2011. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. Available at http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf (Accessed December, 20th 2011).
  23. Ripsin CM, Kang H, Urban RJ. Management of blood glucose in type 2 diabetes mellitus. Am Fam Physician 2009. Jan;79(1):29-36

Reference

  1. Rishi Kumar, Rishabha Malviya, Promod Kumar Sharma. Pharmaceutical applications and patents in natural polymer used drug delivery system. Advances in Biological Research, 2015; 9(1): 24-32.
  2. Murugesh Shivashankar, MandalBadal Kumar. A review on interpenetrating polymer network. International Journal of Pharmacy and Pharmaceutical Sciences, 2012; 4(5): 1.
  3. Kulkarni Vishakha S, Butte Kishor D and Rathod Sudha S, Natural Polymers – A Comprehensive Review, International Journal of Research in Pharmaceutical and Biomedical Sciences,2012;3(4):1597-1613.
  4. Radha Rani Earle, Lakshmi Usha Ayalasomayajula, G. Loknadh, K.Sai Ram Konda Reddy, L. Ratnakanth, A Review on Natural Polymers Used in Pharmaceutical Dosage     Forms,        International Journal of Science and Research Methodology,2016;3(3):77-88.
  5. Vinod KR, Santos V, Sandhya S. Emerging trends in pharmaceutical polymers. Scholars research library 2010; 2 (1): 172-180.
  6. Bhaskar B, Namdeo S, Sunil D, Birudev K. Natural polymers in drug delivery development. Research Journal of Pharmaceutical Dosage Forms and Technology 2014; 6 (1): 54-57.
  7. Sawan K Rathod, Vinod M Thakare and Hemant s Kanhere, Pharmacognostic and Phytochemical evaluation of Blepharis repens, Journal of Pharmacognocy and Phytochemistry;2020;9(2): 805-809.
  8. Tiwari P et al. Phytochemical screening and extraction: A Review International Pharmaceutical Science. 2011; 1:98-106.
  9. Ghebre-SellassieI, Knoch A. Pelletization Techniques. In: SwarbrickJ, Editor. Encyclopedia of Pharmaceutical Technology, 3rd Edition: Informa Healthcare; 2000. P. 2651-63.
  10. Hirjau M, Nicoara AC, Hirjau V, LupuleasaD.Pelletization techniques used in pharmaceutical fields. PracticaFarmaceutic? 2011; 4 (3-4): 206- 11.
  11. Rahman MA, Ahuja A, BabootaS.Bhavna, Bali V, Saigal N, Ali J. Recent Advances in Pelletization Technique for Oral Drug Delivery: A Review. Current Drug Delivery 2009; 6:122-129. http://dx.doi.org/ 10.2174/156720109787048339 PMid:19418964.
  12. Shettigar R, Damle AV. Controlled release pellets of nitrofurantoin; Ind. J. Pharm. Sci.1996; 5: 179-85.
  13. Helen L, Yliruusi J, Muttonen E. Process Variables of the Radial Screen Extruder, II, Size and Size Distribution of Pellets. Pharm. Tech. Int. 1993, 1, 44–53.
  14. Shah RD, Kabadi M, Pope DG, AugsburgerLL.Physicomechanical characterization of the extrusion-spheronization process. Pharm Res1995; 12: 496– 507.http://dx.doi.org/10.1023/A:1016237509740 PMid:7596983.
  15. Catherine Berthomieu Rainer Hienerwade, Fourier transform infrared (FTIR) spectroscopy, Photosynth Res (2009) 101:157–170.
  16. Madiraju AK, Erion DM, Rahimi Y, et al. Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase. Nature. 2014; 510:542– 546. doi: 10.1038/nature13270.
  17. Griffin SJ, Leaver JK, Irving GJ (2017) Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with type 2 diabetes. Diabetologia DOI:10.1007/s00125-017-4337-9
  18. Cameron AR, Morrison VL, Levin D, et al. Anti-inflammatory effects of metformin irrespective of diabetes status. Circ Res. 2016; 119:652–665. doi: 10.1161/CIRCRESAHA.116.308445.
  19. Bannister CA, Holden SE, Jenkins-Jones S, et al. Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls. Diabetes Obes Metab. 2014; 16:1165–1173. doi: 10.1111/dom.12354.
  20. Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus: present and future perspectives. Nature reviews endocrinology. Available at: www.nature.com/uidfinder (Accessed 22nd December 2011)
  21. Genetic basis of type 1 and type2 diabetes, obesity, and their complications. Advances and emerging opportunities in diabetes research: a Strategic Planning report of the DMICC. www2.niddk.nih.gov/NR (Accessed 22nd December 2011).
  22. Department of Health and Human Services. Centres for Disease Control and Prevention, 2011. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. Available at http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf (Accessed December, 20th 2011).
  23. Ripsin CM, Kang H, Urban RJ. Management of blood glucose in type 2 diabetes mellitus. Am Fam Physician 2009. Jan;79(1):29-36

Photo
Rutuja Giram
Corresponding author

Anuradha College of Pharmacy, Chikhali

Photo
Diptee Bhagwat
Co-author

Anuradha College of Pharmacy, Chikhali

Photo
Dr. K. R. Biyani
Co-author

Anuradha College of Pharmacy, Chikhali

Rutuja Giram*, Diptee Bhagwat, Dr. K. R. Biyani, Formulation and Evaluation of Sustained Release Pellets of Oral Antidiabetic Agent by Using Natural Polymer, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 5, 3060-3065. https://doi.org/10.5281/zenodo.15458667

More related articles
Review On Efficacy of Chewable Tablets in Improvin...
Rutuja Mundhe, Dr. Pavan Folane, Dr. K. R. Biyani, ...
Development and Evaluation of Sustained Release Ma...
Payal Mohaniya, Neelam Patel, Rajat Pawar, Deepti Modi, ...
Green Solutions for Better Medicine: Natural Bioav...
Kalyani Parihar, Dr. H. A. Sawarkar, Dr. K. R. Biyani, ...
Formulation And Evaluation of Pellets...
Anisha Kohale, Dr. A. V. Chandewar, Dr. S. R.Gawande, Abhay Dhakare, Anjali Bhansali, Ashwini Warank...
Formulation And Evaluation of Pulsatile Drug Delivery System ...
Rahul Mante, Dr. R. S. Radke, Dr. Aijaz Sheikh, Dr. K. R. Biyani, ...
Formulation And Evaluation Of Colon Target Matrix Tablet Of Mesalamine Using Syn...
Ritesh Rana, Akshit Sharma, Parshuram Rai, Priyanka Devi, ...
Related Articles
SGLT Inhibitors As Antidiabetic Agents...
Atul Kshirasagar, Ms. Priyanka Zendekar, Dr. Gajanan Sanap, ...
A Comprehensive Review on Parenterals...
Rutuja Giram, Diptee Bhagwat , Ashvini Kakad, Aarti Nimse , ...
Formulation And Evaluation of Pellets...
Anisha Kohale, Dr. A. V. Chandewar, Dr. S. R.Gawande, Abhay Dhakare, Anjali Bhansali, Ashwini Warank...
Review On Efficacy of Chewable Tablets in Improving Oral Drug Delivery...
Rutuja Mundhe, Dr. Pavan Folane, Dr. K. R. Biyani, ...
More related articles
Review On Efficacy of Chewable Tablets in Improving Oral Drug Delivery...
Rutuja Mundhe, Dr. Pavan Folane, Dr. K. R. Biyani, ...
Development and Evaluation of Sustained Release Matrix Tablet of Naproxen Using ...
Payal Mohaniya, Neelam Patel, Rajat Pawar, Deepti Modi, ...
Green Solutions for Better Medicine: Natural Bioavailability Enhancers in Drug F...
Kalyani Parihar, Dr. H. A. Sawarkar, Dr. K. R. Biyani, ...
Review On Efficacy of Chewable Tablets in Improving Oral Drug Delivery...
Rutuja Mundhe, Dr. Pavan Folane, Dr. K. R. Biyani, ...
Development and Evaluation of Sustained Release Matrix Tablet of Naproxen Using ...
Payal Mohaniya, Neelam Patel, Rajat Pawar, Deepti Modi, ...
Green Solutions for Better Medicine: Natural Bioavailability Enhancers in Drug F...
Kalyani Parihar, Dr. H. A. Sawarkar, Dr. K. R. Biyani, ...